These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35574319)

  • 21. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
    Chang EC; Frasor J; Komm B; Katzenellenbogen BS
    Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen Receptor β as a Possible Double-Edged Sword Molecule in Breast Cancer: A Mechanism of Alteration of Its Role by Exposure to Endocrine-Disrupting Chemicals.
    Hirao-Suzuki M
    Biol Pharm Bull; 2021; 44(11):1594-1597. PubMed ID: 34719637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.
    Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V
    Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA; Thompson LU
    Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisphenol AF as an Inducer of Estrogen Receptor β (ERβ): Evidence for Anti-estrogenic Effects at Higher Concentrations in Human Breast Cancer Cells.
    Okazaki H; Takeda S; Kakizoe K; Taniguchi A; Tokuyasu M; Himeno T; Ishii H; Kohro-Ikeda E; Haraguchi K; Watanabe K; Aramaki H
    Biol Pharm Bull; 2017; 40(11):1909-1916. PubMed ID: 29093337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.
    Shanle EK; Hawse JR; Xu W
    Biochem Pharmacol; 2011 Dec; 82(12):1940-9. PubMed ID: 21924251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential estrogen receptor β ligands reduce Bcl-2 expression in hormone-resistant breast cancer cells to increase autophagy.
    Ruddy SC; Lau R; Cabrita MA; McGregor C; McKay BC; Murphy LC; Wright JS; Durst T; Pratt MA
    Mol Cancer Ther; 2014 Jul; 13(7):1882-93. PubMed ID: 24785256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer.
    Reese JM; Suman VJ; Subramaniam M; Wu X; Negron V; Gingery A; Pitel KS; Shah SS; Cunliffe HE; McCullough AE; Pockaj BA; Couch FJ; Olson JE; Reynolds C; Lingle WL; Spelsberg TC; Goetz MP; Ingle JN; Hawse JR
    BMC Cancer; 2014 Oct; 14():749. PubMed ID: 25288324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
    Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity.
    Lindberg K; Helguero LA; Omoto Y; Gustafsson JÅ; Haldosén LA
    Breast Cancer Res; 2011 Apr; 13(2):R43. PubMed ID: 21492444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ERbeta in breast cancer--onlooker, passive player, or active protector?
    Fox EM; Davis RJ; Shupnik MA
    Steroids; 2008 Oct; 73(11):1039-51. PubMed ID: 18501937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation.
    Teng J; Wang ZY; Jarrard DF; Bjorling DE
    Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.
    Galea GL; Meakin LB; Sugiyama T; Zebda N; Sunters A; Taipaleenmaki H; Stein GS; van Wijnen AJ; Lanyon LE; Price JS
    J Biol Chem; 2013 Mar; 288(13):9035-48. PubMed ID: 23362266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
    Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists.
    Paruthiyil S; Cvoro A; Zhao X; Wu Z; Sui Y; Staub RE; Baggett S; Herber CB; Griffin C; Tagliaferri M; Harris HA; Cohen I; Bjeldanes LF; Speed TP; Schaufele F; Leitman DC
    PLoS One; 2009 Jul; 4(7):e6271. PubMed ID: 19609440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
    Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
    J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
    Mishra AK; Abrahamsson A; Dabrosin C
    Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.